🇺🇸 FDA
Patent

US 9132107

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

granted A61KA61K31/19A61K31/554

Quick answer

US patent 9132107 (Gamma-hydroxybutyrate compositions and their use for the treatment of disorders) held by Jazz Pharmaceuticals Ireland Limited expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/19, A61K31/554, A61K9/0053, A61K9/08